Biosimilar Enoxaparin for the Prevention or Treatment of Thrombosis and Cardiovascular Conditions

Details

Files

Project Status:

Completed

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1589-000

Question

What is the clinical effectiveness for adult or pediatric patients of switching from reference to biosimilar enoxaparin in the prevention or treatment of thrombosis and cardiovascular conditions?
What is the comparative clinical effectiveness for adult or pediatric patients of biosimilar versus reference enoxaparin for in prevention or treatment of thrombosis and cardiovascular conditions?

Key Message

Three randomized controlled trials and 1 non-randomized study were identified regarding the comparative clinical effectiveness of biosimilar versus reference enoxaparin in the prevention or treatment of thrombosis and cardiovascular conditions for adult or pediatric patients. No relevant literature was identified regarding the clinical effectiveness of switching from reference to biosimilar enoxaparin in the prevention or treatment of thrombosis and cardiovascular conditions for adult or pediatric patients

Files

Le biosimilaire de l’énoxaparine dans la prévention ou le traitement de la thrombose et des maladies cardiovasculaires View PDF

Last Updated : September 10, 2021